FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021306876> ?p ?o ?g. }

• W2021306876 endingPage "126" @default.
• W2021306876 startingPage "119" @default.
• W2021306876 abstract "The current standard-of-care therapy in HCV consists in ribavirin (RBV) plus pegylated-interferon-α 2a or 2b and, for HCV-1 infected patients, also directly acting antivirals (DAAs). Despite the increase in the number of patients who reach sustained virological response (SVR) for HCV-1, a great inter-individual variability in the response to therapy remains. Whether new drugs are available in combination with RBV and Peg-IFN for HCV-1, the treatment of the other viral genotypes remains the same: this issue highlights the lasting importance of RBV and Peg-IFN in anti-HCV treatment. Moreover, a strong limiting factor to the usefulness of anti-HCV treatment remains the occurrence of adverse events, first of all hemolytic anemia, which have increased with the addition of DAAs, but is mainly an RBV-dependent effect. For these reasons, the monitoring of RBV exposure in the various compartments should be important. Since the routinely determination of RBV in the target cells as the hepatocytes is impracticable for of its invasiveness, the quantification in easier to obtain cells could be a good choice. In this work, we developed and validated an ultra performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) assay method to quantify RBV concentrations in peripheral blood mononucleated cells (PBMCs). QCs were prepared with RBV and RBV-monophosphate (RMP). Each sample was divided into two aliquots, which undergone the same extraction procedure: one was treated with acid phosphatase to convert RBV phosphorylated metabolites into free RBV, the other one was not-treated. The extracts were analyzed with reverse-phase column with UPLC–MS/MS. Calibration curves fitted a least squares model (weighed 1/X) for ribavirin levels in a range from 0.1 ng to 200 ng (mean r2 = 0.9993). Accuracy, intra-day and inter-day precision of the methods were in accordance with FDA guidelines. Moreover, phosphorylated QCs were used to assess the correct determination of total RBV concentration. We tested this method by monitoring RBV concentrations in PBMCs from 20 HCV+ patients, receiving alpha interferon-plus RBV combination therapy. This method showed to be reliable, precise, accurate and suitable for evaluation of intracellular RBV concentrations." @default.
• W2021306876 created "2016-06-24" @default.
• W2021306876 creator A5003451849 @default.
• W2021306876 creator A5005473694 @default.
• W2021306876 creator A5020133322 @default.
• W2021306876 creator A5021206943 @default.
• W2021306876 creator A5076836884 @default.
• W2021306876 creator A5079779731 @default.
• W2021306876 creator A5082095996 @default.
• W2021306876 date "2014-03-01" @default.
• W2021306876 modified "2023-10-17" @default.
• W2021306876 title "Development and validation of a useful UPLC–MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients" @default.
• W2021306876 cites W1631951433 @default.
• W2021306876 cites W1969511656 @default.
• W2021306876 cites W1970901457 @default.
• W2021306876 cites W1976406734 @default.
• W2021306876 cites W1979174109 @default.
• W2021306876 cites W1982293144 @default.
• W2021306876 cites W1982691320 @default.
• W2021306876 cites W1984434919 @default.
• W2021306876 cites W1984521402 @default.
• W2021306876 cites W1987116001 @default.
• W2021306876 cites W1992951290 @default.
• W2021306876 cites W1997755547 @default.
• W2021306876 cites W2001717846 @default.
• W2021306876 cites W2005910303 @default.
• W2021306876 cites W2011720547 @default.
• W2021306876 cites W2022654026 @default.
• W2021306876 cites W2026595409 @default.
• W2021306876 cites W2026614040 @default.
• W2021306876 cites W2031419285 @default.
• W2021306876 cites W2041590441 @default.
• W2021306876 cites W2044984820 @default.
• W2021306876 cites W2048513746 @default.
• W2021306876 cites W2052464630 @default.
• W2021306876 cites W2063419900 @default.
• W2021306876 cites W2064546869 @default.
• W2021306876 cites W2073309298 @default.
• W2021306876 cites W2080132408 @default.
• W2021306876 cites W2092710527 @default.
• W2021306876 cites W2099936859 @default.
• W2021306876 cites W2103707468 @default.
• W2021306876 cites W2103742920 @default.
• W2021306876 cites W2104872369 @default.
• W2021306876 cites W2107426863 @default.
• W2021306876 cites W2108669368 @default.
• W2021306876 cites W2111479433 @default.
• W2021306876 cites W2113864802 @default.
• W2021306876 cites W2135624863 @default.
• W2021306876 cites W2136329836 @default.
• W2021306876 cites W2143842259 @default.
• W2021306876 cites W2146121203 @default.
• W2021306876 cites W2160244819 @default.
• W2021306876 cites W2160930473 @default.
• W2021306876 cites W2164275961 @default.
• W2021306876 cites W2166671813 @default.
• W2021306876 cites W2171821562 @default.
• W2021306876 cites W2334943495 @default.
• W2021306876 cites W4244312606 @default.
• W2021306876 doi "https://doi.org/10.1016/j.jpba.2013.11.027" @default.
• W2021306876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24366212" @default.
• W2021306876 hasPublicationYear "2014" @default.
• W2021306876 type Work @default.
• W2021306876 sameAs 2021306876 @default.
• W2021306876 citedByCount "19" @default.
• W2021306876 countsByYear W20213068762014 @default.
• W2021306876 countsByYear W20213068762015 @default.
• W2021306876 countsByYear W20213068762016 @default.
• W2021306876 countsByYear W20213068762017 @default.
• W2021306876 countsByYear W20213068762019 @default.
• W2021306876 countsByYear W20213068762020 @default.
• W2021306876 countsByYear W20213068762021 @default.
• W2021306876 countsByYear W20213068762022 @default.
• W2021306876 crossrefType "journal-article" @default.
• W2021306876 hasAuthorship W2021306876A5003451849 @default.
• W2021306876 hasAuthorship W2021306876A5005473694 @default.
• W2021306876 hasAuthorship W2021306876A5020133322 @default.
• W2021306876 hasAuthorship W2021306876A5021206943 @default.
• W2021306876 hasAuthorship W2021306876A5076836884 @default.
• W2021306876 hasAuthorship W2021306876A5079779731 @default.
• W2021306876 hasAuthorship W2021306876A5082095996 @default.
• W2021306876 hasConcept C137061746 @default.
• W2021306876 hasConcept C159047783 @default.
• W2021306876 hasConcept C185592680 @default.
• W2021306876 hasConcept C202751555 @default.
• W2021306876 hasConcept C2522874641 @default.
• W2021306876 hasConcept C2776178377 @default.
• W2021306876 hasConcept C2776408679 @default.
• W2021306876 hasConcept C2776455275 @default.
• W2021306876 hasConcept C2776461080 @default.
• W2021306876 hasConcept C2780040827 @default.
• W2021306876 hasConcept C2909179924 @default.
• W2021306876 hasConcept C43617362 @default.
• W2021306876 hasConcept C55493867 @default.
• W2021306876 hasConcept C71924100 @default.
• W2021306876 hasConcept C98274493 @default.
• W2021306876 hasConceptScore W2021306876C137061746 @default.
• W2021306876 hasConceptScore W2021306876C159047783 @default.

• next